- Udyam number
- UDYAM-GJ-25-0007199

About Alcon Biosciences Private Limited
Data last updated:
Alcon Biosciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 19 April 1982 and has been in existence for over 44 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1982PTC026953. Its GSTIN is 27AAACA5119P1ZH (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1.1 Cr and a paid-up capital of ₹1.03 Cr. It was formerly known as Alcon Pharamaceuticals Private Limited. It is led by directors including Advait Jajodia and Ashutosh Radheshyam Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 112 Marine Chambers 11 New Marine Lines, Mumbai, Maharashtra, India – 400020.
As per the financials filed for FY 2025, the company reported a revenue of ₹125.22 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹9.57 Cr (net margin 7.6%) and EBITDA of ₹15.23 Cr (EBITDA margin 12.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 7% over five years.
The company has about 108 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Alcon Biosciences. As per MCA filings, the company has open charges of ₹24.22 Cr and satisfied charges of ₹37.16 Cr on record. Court records list 13 cases involving the company, including 11 filed by the company and 2 filed against it; 4 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2.55 Cr; the latest was in March 2017. Its 8 peer companies in the Pharma industry (API Manufacturers, Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Coral Drugs Private Limited with revenue of ₹126.9 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2024, listing 1,044 overdue payments to 111 micro and small suppliers.
Alcon Biosciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-25-0007199). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alconpharma.com.
Company details
Recognitions & Rankings of Alcon Biosciences
Contact details
Alcon Biosciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is alconpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address112 Marine Chambers 11 New Marine Lines, Mumbai, Maharashtra, India – 400020
- IndustryPharma, API Manufacturers
To see the full contact details of Alcon Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Alcon Biosciences operates one associated brand: Alcon Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| CDMO focused on manufacturing of API | alconpharma.com |
Business activity
The main business activity of Alcon Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alcon Biosciences Private Limited, buy the company report.
Financials of Alcon Biosciences Private Limited
FY 2025 filings availableAlcon Biosciences Private Limited reported revenue of ₹125.22 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 10% growth in the latest year. EBITDA rose 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.2% | ||||
| Net Profit Margin | 7.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alcon Biosciences Private Limited, buy the company report.
Board of directors of Alcon Biosciences Private Limited
Alcon Biosciences has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Advait Jajodia | Director | 24 Jun 2023 | 3 Years 4 Months | Current |
| Ashutosh Radheshyam Tripathi Also directs: Swati Speciality Private Limited | Director | 01 Sep 2025 | 1 Years 1 Months | Current |
| Vishal Narayanprasad Jajodia | Director | 07 Dec 2003 | 22 Years 10 Months | Current |
Peer comparison
Alcon Biosciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Coral Drugs Private Limited | ₹126.9 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Sohan Healthcare Private Limited | ₹126.69 Cr (FY 2025) | 6.0% | Yavatmal, Maharashtra, India | |||
| Corey Organics Private Limited | ₹126.33 Cr (FY 2025) | -6.0% | Hyderabad, Telangana, India | |||
| Smruthi Organics Ltd | ₹126.1 Cr (FY 2025) | -1.0% | Solapur, Maharashtra, India | |||
| Alcon Biosciences Private Limitedthis company | ₹125.22 Cr (FY 2025) | ₹9.57 Cr | 7.6% | 10.0% | 108 | Mumbai, Maharashtra, India |
| Quad Lifesciences Private Limited | ₹123.66 Cr (FY 2025) | 26.0% | Derabassi, Punjab, India | |||
| Roopa Industries Limited | ₹122.98 Cr (FY 2025) | 72.0% | Kurnool, A.P, Andhra Pradesh, India | |||
| Richter Themis Medicare (India) Private Limited | ₹122.69 Cr (FY 2025) | -13.0% | Valsad, Gujarat, India | |||
| Nuray Chemicals Private Limited | ₹122.27 Cr (FY 2025) | 16.0% | Thiruvallur, Tamil Nadu, India |
To see the full peer comparison of Alcon Biosciences Private Limited, buy the company report.
Auditor
Alcon Biosciences Private Limited is audited by Vinod S. Mehta & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vinod S. Mehta & Co. | FY 2024 | 111524W |
Shareholding
The shareholding of Alcon Biosciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alcon Biosciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2022 | 100609238 | Hdfc Bank Limited | ₹2.7 Cr | Open | |
| 11 Jan 2022 | 100530433 | Others | ₹2.41 Cr | Open | |
| 27 Jun 1998 | 90229362 | Others | ₹19.11 Cr | Open | |
| 04 Jan 2011 | 10265344 | Union Bank of India | ₹20.96 Cr | Satisfied | |
| 10 Oct 2009 | 10188646 | Union Bank of India | ₹14.5 Cr | Satisfied |
To see the full charge records of Alcon Biosciences Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Alcon Biosciences Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2.55 Cr; the latest was in March 2017.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Arpita Tradelink Private Limited , Andhan Trade Link Private Limited, Hemang Fincap Services Private Limited |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2012 | Funding round | ₹2.55 Cr | Investors: Lark Chemicals Private Limited , Hemang Fincap Services Private Limited , Andhan Trade Link Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Alcon Biosciences Private Limited has 13 court cases on record: 11 filed by Alcon Biosciences, 2 filed against it. 4 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 2 | 2 |
| High courts | 6 | 0 | 2 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against Prizam Alliance Private Limited and 2 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against Lifespan Biotech Pvt Ltd and 2 others | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against SVC Co Operative Bank Limited and Anr. | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| Bombay High Court | Appeal | Filed by the company against SVC Co Operative Bank Limited and Anr. | Disposed |
To see the full case history of Alcon Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Alcon Biosciences Private Limited was last rated by Crisil on 16 Mar 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 16 Mar 2020 |
To see the full credit ratings and regulatory alerts of Alcon Biosciences Private Limited, buy the company report.
MSME payment delays
Alcon Biosciences Private Limited has 11 MSME Form 1 returns on record between 2019 and 2024, listing 1,044 overdue payments to 111 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 111)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Shah Chemical | |||
| an individual supplier | |||
| Prachin Chemical | |||
| Sohan Healthcare Private Limited | |||
| Dayaram Chemicals Private Limited |
To see the full MSME payment records of Alcon Biosciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Alcon Biosciences Private Limited has a workforce of 108 employees on its EPFO records as of Nov 25, 2024, across 1 active EPFO establishment.
GST
Alcon Biosciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACA5119P1ZH | Maharashtra | Active | 01 Jul 2017 |
| 24AAACA5119P1ZN | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alcon Biosciences Private Limited, buy the company report.
Recent activity
Alcon Biosciences Private Limited has 9 board changes on record since 2003: 3 appointments and 6 cessations. The latest: Ashutosh Radheshyam Tripathi was appointed as Director on 01 Sep 2025.
13 earlier events are in the company report.
Frequently asked questions
Alcon Biosciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 19 April 1982 (44+ years old) and is registered under CIN U24230MH1982PTC026953.
Alcon Biosciences has 3 current directors:
- Advait Jajodia - Director
- Ashutosh Radheshyam Tripathi - Director
- Vishal Narayanprasad Jajodia - Director
The latest financial statements of Alcon Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Alcon Biosciences is 27AAACA5119P1ZH, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACA5119P1ZN (Gujarat).
The CIN (Corporate Identification Number) of Alcon Biosciences is U24230MH1982PTC026953. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alcon Biosciences has 13 court cases on record: 11 filed by the company and 2 filed against it. 4 are pending. Most are in the district courts.
Alcon Biosciences was incorporated on 19 April 1982, making it 44+ years old. It is registered with the Registrar of Companies, Mumbai.
Alcon Biosciences has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2.55 Cr; the latest was in March 2017.
The peers of Alcon Biosciences by revenue are Coral Drugs Private Limited, Sohan Healthcare Private Limited, Corey Organics Private Limited, Smruthi Organics Ltd, Quad Lifesciences Private Limited and 3 more, all in the Pharma industry (API Manufacturers, Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashutosh Radheshyam Tripathi was appointed as Director on 01 Sep 2025. Rakesh Ayodhyaprasad Pandey ceased to be Director on 07 Nov 2023. Kalpesh Sharma ceased to be Additional Director on 29 Sep 2023. Alcon Biosciences has 9 board changes on record in total.
Yes, Alcon Biosciences is registered as an MSME under Udyam registration (number: UDYAM-GJ-25-0007199).
Alcon Biosciences has 11 MSME Form 1 returns on record between 2019 and 2024, listing 1,044 overdue payments to 111 micro and small suppliers. The latest return was filed on 30 Apr 2024.

